A new, privately funded venture has announced that it has recruited more than 20 top scientists and is pouring $15 million raised so far into LongCovid research, with plans to launch clinical trials of treatments as soon as possible.
A new, privately funded venture announced today it has recruited more than 20 top scientists and is pouring $15 million raised so far into Long Covid research, with plans to launch clinical trials of treatments as soon as possible. The scientist who spearheaded the Long Covid Research Initiative , microbiologist Amy Proal at the Washington state–based nonprofit PolyBio Research Foundation, says the goal is to bring in $100 million.
NIH said in a statement that the agency welcomes the private initiative because “the public can only benefit from multiple research efforts.” However, the statement called RECOVER “unprecedented” in scale and aim, and said the giant effort will be crucial to giving researchers “a fighting chance at identifying the underlying mechanisms of Long COVID.”
The Centers for Disease Control and Prevention estimates more than 40% of U.S. adults have reported contracting COVID-19; of those,may have persistent symptoms. In the months after an infection with the SARS-CoV-2 coronavirus, Long Covid patients can experience crushing fatigue; difficulty thinking; shortness of breath, especially on exertion; and assorted other symptoms.
If virus is lingering in the body, antiviral therapies might reduce symptoms. Proal hopes the collaborative can soon begin clinical trials of such therapies, and that its scientists can nail down the kind of biomarkers drug companies crave. “We really think there are tangible outcome measures” that will make assessing therapies more straightforward, Proal says. These could include certain immune signatures or other measures in blood.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Using Hyperbaric Oxygen Treatment to treat long covidAn old treatment provides new relief for people suffering from debilitating conditions associated with long COVID-19.
続きを読む »
Beyond tired: Why fatigue sets in and how to tackle itFor decades, fatigue was dismissed as a fuzzy symptom with no clear biological origin. New research is revealing that it is anything but Here’s what we know about fatigue, and the exciting new avenues for treatment:
続きを読む »
Proximity bias among top fears of remote workers - Jacksonville Business JournalThis week's Playbook Edition takes a closer look at proximity bias in the hybrid workplace, the effects of long Covid and why $20 is the new $15.
続きを読む »
Stress, anxiety or depression may increase long Covid risk: studyPeople who were experiencing psychological distress before getting Covid were more likely to have long-lasting symptoms than those who were not, according to new research.
続きを読む »
New research initiative will focus on root causes of long COVIDA new research initiative will explore whether the persistence of coronavirus in the body plays a role in the development of long COVID.
続きを読む »